Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 489 |
---|---|
Genomic Coordinate (GRCh38) | g.22190443G>C |
Variant | c.1587-1G>C |
Variant Start Position | 1587 |
Location | Intron 14 |
Amino Acid Change | p.? |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Splice acceptor |
Variant Type | Splicing |
PMID | 28506344, 31903094, 22695891, 34806794 |
Article Count | 4 |
Times Observed | 6-10 |
Clinical Phenotype | - |
ACMG Categories | pvs1, pm2, ppc |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22208560 ref:G alt:C was not found in gnomAD exomes or genomes. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | ppc |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22208560-G-C |
GnomAD Alleles | - |
DBNSFP Alleles | X-22208560-G-C |
Other Alleles | - |
Note | nan |
Warnings | - |